RM

Ravindra Madamanchi

Active Director Director DIN 07260574
DIN 07260574 First appointment Aug 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2015
Shareholding value •••• Premium profile

About Ravindra Madamanchi

Data last updated:

Ravindra Madamanchi is a Director at Mendel Pharma Private Limited (since 2015). The company operates in Pharma. Mendel Pharma Private Limited reported revenue of ₹2.21 Cr (FY 2024).

DIN 07260574
Primary Designation Director
Industry Pharma
First Appointment 11 Aug 2015
Oldest Company Age 22 yrs
Largest company Mendel Pharma Private Limited · ₹2.21 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mendel Pharma Private Limited U24239TG2004PTC043103
Director11 Aug 20152004₹2.21 Cr (FY 2024)Active

Board colleagues of Ravindra Madamanchi

Directorship timeline

Open interactive timeline →
Mendel Pharma Private Limited
Premium access

Shareholding and investment profile for Ravindra Madamanchi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravindra Madamanchi

Ravindra Madamanchi currently holds 1 directorship: Mendel Pharma Private Limited (Director, since 11 Aug 2015, revenue ₹2.21 Cr (FY 2024)).

Ravindra Madamanchi was first appointed on 11 Aug 2015 as Director at Mendel Pharma Private Limited.

The current boards of Ravindra Madamanchi's companies include Lakshminarayna Marepalli (Mendel Pharma Private Limited), Madamanchi Padmasharani (Mendel Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available